HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Peyron Selected Research

F Peyron Research Topics

Disease

12Infections
05/2023 - 01/2000
3Congenital Toxoplasmosis
10/2021 - 02/2001
3Toxoplasmosis
11/2006 - 08/2001
2Cysts
03/2000 - 01/2000
1Rupture
12/2021
1Larva Migrans (Cutaneous Larva Migrans)
04/2019
1Cutaneous Leishmaniasis
11/2013
1Ocular Toxoplasmosis
03/2009
1Vivax Malaria
03/2005
1Malaria
07/2001
1Mycoses (Diseases, Fungus)
01/2001
1Encephalitis (Encephalitis, Rasmussen)
03/2000

Drug/Important Bio-Agent (IBA)

4Pyrimethamine (Daraprim)FDA Link
10/2021 - 02/2001
4Immunoglobulin G (IgG)IBA
03/2007 - 03/2003
3Immunoglobulin M (IgM)IBA
05/2023 - 03/2003
3SpiramycinIBA
10/2021 - 09/2002
2Anti-Bacterial Agents (Antibiotics)IBA
03/2009 - 01/2000
2AntibodiesIBA
06/2004 - 03/2003
2AntigensIBA
03/2003 - 05/2002
1Leucovorin (Folinic Acid)FDA Link
10/2021
1Sulfadiazine (Sulphadiazine)FDA Link
10/2021
1Albendazole (Albenza)FDA Link
04/2019
1Ointments (Pastes)IBA
04/2019
1Cell Surface ReceptorsIBA
01/2007
1Chemokine ReceptorsIBA
01/2007
1pyrimethamine drug combination fanasil (Fansidar)FDA Link
03/2005
1proguanil drug combination atovaquone (malarone)FDA Link
03/2005
1Chloroquine (Aralen)FDA LinkGeneric
03/2005
1Mefloquine (Lariam)FDA LinkGeneric
03/2005
1Peptides (Polypeptides)IBA
05/2002
1SulfonamidesIBA
02/2001
1Amphotericin B (Amphotericin)FDA LinkGeneric
01/2001
1Didanosine (Videx)FDA LinkGeneric
03/2000
1drug combination magnesium hydroxide aluminum hydroxide (Maalox)IBA
03/2000
1artenimol (dihydroartemisinin)IBA
01/2000
1ArtesunateIBA
01/2000

Therapy/Procedure

2Therapeutics
10/2021 - 11/2013
1Parenteral Nutrition
12/2021
1Secondary Prevention
08/2001
1Drug Therapy (Chemotherapy)
08/2001
1Chemoprevention
07/2001
1Duration of Therapy
02/2001